We subsequently determined that tumors from UM patients upregulate and require INPP5A by comparing nonredundant, curated sets of tumor transcriptomic and genomic data (cBioPortal) from UM (80 samples) and skin cutaneous melanoma (SKCM; 488 samples) patients. Here, INPP5A is linked to neoplasm.